Gut Microbiota Functional Dysbiosis Relates to Individual Diet in Subclinical Carotid Atherosclerosis

Gut Microbiota Functional Dysbiosis Relates to Individual Diet in Subclinical Carotid Atherosclerosis

Gut Microbiota (GM) dysbiosis associates with Atherosclerotic Cardiovascular Diseases (ACVD), but whether this also holds true in subjects without clinically manifest ACVD represents a challenge of personalized prevention. We connected exposure to diet (self-reported by food diaries) and markers of...

Full description

Bibliographic Details
Main Authors:	Andrea Baragetti, Marco Severgnini, Elena Olmastroni, Carola Conca Dioguardi, Elisa Mattavelli, Andrea Angius, Luca Rotta, Javier Cibella, Giada Caredda, Clarissa Consolandi, Liliana Grigore, Fabio Pellegatta, Flavio Giavarini, Donatella Caruso, Giuseppe Danilo Norata, Alberico Luigi Catapano, Clelia Peano
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Nutrients
Subjects:	Atherosclerotic Cardiovascular Diseases Gut Microbiota next generation sequencing
Online Access:	https://www.mdpi.com/2072-6643/13/2/304

Similar Items

Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
by: Elisa Mattavelli, et al.
Published: (2023-04-01)

Adherence to the Mediterranean Diet: Impact of Geographical Location of the Observations
by: Elisa Mattavelli, et al.
Published: (2022-05-01)

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?
by: Elisa Mattavelli, et al.
Published: (2021-10-01)

IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.
by: Ashish Dhyani, et al.
Published: (2015-01-01)

Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease
by: Andrea Baragetti, et al.
Published: (2020-07-01)

Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events
by: Marco Magnoni, et al.
Published: (2022-12-01)

High dietary inflammatory index associates with inflammatory proteins in plasma
by: Elisa Mattavelli, et al.
Published: (2024-02-01)

<i>Bacteroides fragilis</i> Supplementation Deteriorated Metabolic Dysfunction, Inflammation, and Aorta Atherosclerosis by Inducing Gut Microbiota Dysbiosis in Animal Model
by: Guoxiang Shi, et al.
Published: (2022-05-01)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
by: Liliana Grigore, et al.
Published: (2008-04-01)

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease
by: Andrea Baragetti, et al.
Published: (2020-06-01)

Señales ateroscleróticas tempranas en el escolar con antecedentes de alto peso al nacer
by: Nuris Rodríguez Vargas, et al.

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
by: Federica Galimberti, et al.
Published: (2023-09-01)

Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)
by: Ji Youn Yoo, et al.
Published: (2022-01-01)

Atherosclerotic Plaque Characterization Methods Based on Coronary Imaging /
by: Athanasiou, Lambros S., author 649677, et al.
Published: (2017)

New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
by: Meng-Yu Wu, et al.
Published: (2017-09-01)

Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI studyResearch in context
by: Julia Brandts, et al.
Published: (2023-08-01)

Spectral Differences Between Normal and Atherosclerotic Aorta
by: Nikolay Korovin
Published: (2020-12-01)

Association between triglyceride-glucose index and intracranial/extracranial atherosclerotic stenosis: findings from a retrospective study
by: Yu Xie, et al.
Published: (2024-03-01)

Current smoking is associated with extracranial carotid atherosclerotic stenosis but not with intracranial large artery disease
by: Ruijun Ji, et al.
Published: (2017-06-01)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
by: Manuela Casula, et al.
Published: (2021-07-01)

The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review
by: Nikolaos PE Kadoglou, et al.
Published: (2024-01-01)

Longevity-associated BPIFB4 gene counteracts the inflammatory signaling
by: Monica Cattaneo, et al.
Published: (2024-03-01)

Macrophage Phenotyping in Atherosclerosis by Proteomics
by: Sonia Eligini, et al.
Published: (2023-01-01)

The Influence of Calcification Factors and Endothelial-Dysfunction Factors on the Development of Unstable Atherosclerotic Plaques
by: Yana V. Polonskaya, et al.
Published: (2020-12-01)

The Association of Proprotein Convertase Subtilisin/Kexin Type 9 to Plasma Low-Density Lipoproteins: An Evaluation of Different Methods
by: Laura Canclini, et al.
Published: (2021-12-01)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
by: Elena Olmastroni, et al.
Published: (2022-12-01)

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
by: Anna Ludovica Fracanzani, et al.
Published: (2016-01-01)

Defective efferocytosis of vascular cells in heart disease
by: Bandana Singh, et al.
Published: (2022-09-01)

Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk
by: Jose María Mostaza, et al.
Published: (2024-03-01)

Pregnancy History at 40 Years of Age as a Marker of Cardiovascular Risk
by: Liv G. Kvalvik, et al.
Published: (2024-03-01)

Evaluate the correlation of Inflammatory Cytokines with Chlamydia pneumonia in Coronary Atherosclerotic Patients
by: Ruqaya M. AL-Barzinji, et al.
Published: (2017-10-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
by: Christie M. Ballantyne, et al.
Published: (2022-08-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
by: Stanisław Surma, et al.
Published: (2021-12-01)

Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques?
by: Marcello Baroni, et al.
Published: (2022-10-01)

Natural language processing to identify reasons for sex disparity in statin prescriptions
by: Celeste Witting, et al.
Published: (2023-06-01)

Penetrating Atherosclerotic Aortic Ulcer
by: Walsh, Ryan, et al.
Published: (2010-12-01)

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study
by: Hyungtae Kim, et al.
Published: (2019-08-01)